Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang(Hebei Medical University), Xiaolong Qi(Zhongda Hospital Southeast University), Yunhong Wu(Wuhou District People's Hospital, Chengdu), Jingwen Ai(Fudan University), Xiaoguo Li(Fudan University), Jingwei Sun(Baoding People's Hospital), Ming‐Hua Zheng(Wenzhou Medical University), Xiaolin Ji(Hebei Medical University), Don C. Rockey(Medical University of South Carolina), Jiansong Ji(Lishui University), Shubo Chen(Hebei Medical University), Fenxiang Li, Shiying Yang(People’s Hospital of Rizhao), Jiangbo Shao(Jiangsu University), Zhiyun Hou(Zoucheng People's Hospital), Zhenhuai Chen(Baoding People's Hospital), Nina Zhang(Nanjing Drum Tower Hospital), Qing Xie(Ruijin Hospital), Dengxiang Liu(Hebei Medical University), Jonathan Fallowfield(Centre for Inflammation Research), Chao Liu(Harbin Medical University), Xing Liu(The Sixth People's Hospital of Shenyang), Yan Yan(Army Medical University), Jianxin Liu(Zhejiang University), Qing‐Yu He(Jinan University), Liting Zhang(First Hospital of Lanzhou University), Fengxian Wang(Jinzhou Central Hospital), Guohong Ge(Jiangsu University), Dan Xu, Chuan Liu(Wuhan University), Shiliang Zhang(University of California, Los Angeles), Aiguo Zhang, Wenhong Zhang(Fudan University), Xue Li(Shandong Provincial QianFoShan Hospital), Yifei Huang(First Hospital of Lanzhou University), Yuanwang Qiu(Wuxi Fourth People's Hospital), Zhongwei Zhao(Central South University), Tao Ren(Tibet Autonomous Region People's Hospital), Ye Gu(The Sixth People's Hospital of Shenyang), Fazong Wu(Wenzhou Medical University), Cheng Lv(The Sixth People's Hospital of Shenyang), Shengqiang Zou(Jiangsu University), Yan Wang(National Institute of Biological Sciences, Beijing), Shiqi Diao
Cited by 101
Related Papers
Liver biopsy†
|Hepatology|2008|1.9k
Vapor-assisted deposition of highly efficient, stable black-phase FAPbI <sub>3</sub> perovskite solar cells
|Science|2020|786
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
|Cell Metabolism|2019|521